Discontinuation of Varenicline may boost e-cigarettes use as alternative nicotine replacement therapy
High levels of cancerogenic nitrosamines have been recently found in the smoking cessation medicine Varenicline (Champix). As a precautionary measure, the drug has been withdrawn from the market and its ...
